Paediatric Range

Classical Unani literature offers an extensive repository of formulations tailored specifically for children. However, translating this traditional knowledge into readily accessible, child-friendly products has remained a persistent challenge. Despite the abundance of paediatric remedies described in classical texts, only a handful have found their way into the contemporary market in usable formats.

In the absence of dedicated paediatric formulations, children—particularly neonates and infants—have traditionally been treated with off-label adult Unani medications. This practice raises concerns, as it compromises both safety and efficacy. Off-label use is especially problematic in children under the age of two, where dosing precision and safety data are often lacking. Practitioners are frequently forced to rely on approximations, increasing the risk of under- or overdosing.

Moreover, children under five years of age generally struggle to swallow solid capsules or tablets larger than 10 mm. Splitting or crushing tablets, while common, often results in inaccurate dosing and inconsistent therapeutic outcomes. Additionally, unpleasant taste and poor mouthfeel can lead to rejection of the medicine, regardless of the dosage form. 

Classification of paediatric age categories.

Taste, volume, and overall palatability are critical factors in paediatric formulations. Children may reject medicines due to bitter or metallic flavours, even if taste-masked. Other factors like flavour profile, sweeteners, pH level, colour, and tongue feel significantly influence acceptance and compliance.

Recognizing these unique challenges, DEHLVI is proud to introduce its dedicated Paediatric Range of Unani Products — thoughtfully developed to offer safe, effective, and child-friendly therapeutic solutions rooted in the wisdom of Unani medicine, alongside select formulations suitable for other age groups as well.